Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Montero

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Gaceta Sanitaria|November 7, 2009
[Gender-based violence against immigrant and Spanish women: scale of the problem, responses and current policies]Carmen Vives-Cases, Diana Gil-González, Juncal Plazaola-Castaño, et al.
Journal of Epidemiology and Community Health|December 6, 2007
A framework to analyse gender bias in epidemiological researchMaría Teresa Ruiz-Cantero, Carmen Vives-Cases, Lucía Artazcoz, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|April 25, 2006
Implementation of evidence-based treatment for schizophrenic disorders: two-year outcome of an international field trial of optimal treatmentIan R H Falloon, Isabel Montero, Mehmet Sungur, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 14, 2013
Patterns of infection in patients with myelodysplastic syndromes and acute myeloid leukemia receiving azacitidine as salvage therapy. Implications for primary antifungal prophylaxisJose F Falantes, Cristina Calderón, Francisco J Márquez-Malaver, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 10, 2012
Clinical prognostic factors for survival and risk of progression to acute myeloid leukemia in patients with myelodysplastic syndromes with < 10% marrow blasts and non-unfavorable cytogenetic categoriesJose F Falantes, Cristina Calderón, Francisco J Márquez Malaver, et al.
Journal of Biomedical Materials Research. Part A|March 27, 2012
Aging of porous silicon in physiological conditions: cell adhesion modes on scaled 1D micropatternsAlvaro Muñoz Noval, Vanessa Sánchez Vaquero, Esther Punzón Quijorna, et al.
European Journal of Haematology|May 24, 2014
Fludarabine, cyclophosphamide and rituximab as first-line treatment in patients with newly diagnosed follicular lymphomaFátima De la Cruz Vicente, Estrella Carrillo-Cruz, Maria Sole Rodriguez, et al.
Haematologica|March 12, 2010
Early intervention during imatinib therapy in patients with newly diagnosed chronic-phase chronic myeloid leukemia: a study of the Spanish PETHEMA groupFrancisco Cervantes, Pilar López-Garrido, María-Isabel Montero, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Overexpression of GYS1, MIF, and MYC is associated with adverse outcome and poor response to azacitidine in myelodysplastic syndromes and acute myeloid leukemiaJose F Falantes, Pablo Trujillo, Jose I Piruat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2016
Immunomodulatory Effect of Vitamin D after Allogeneic Stem Cell Transplantation: Results of a Prospective Multicenter Clinical TrialTeresa Caballero-Velázquez, Isabel Montero, Fermín Sánchez-Guijo, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Gaceta Sanitaria|November 7, 2009
[Gender-based violence against immigrant and Spanish women: scale of the problem, responses and current policies]Carmen Vives-Cases, Diana Gil-González, Juncal Plazaola-Castaño, et al.
Journal of Epidemiology and Community Health|December 6, 2007
A framework to analyse gender bias in epidemiological researchMaría Teresa Ruiz-Cantero, Carmen Vives-Cases, Lucía Artazcoz, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|April 25, 2006
Implementation of evidence-based treatment for schizophrenic disorders: two-year outcome of an international field trial of optimal treatmentIan R H Falloon, Isabel Montero, Mehmet Sungur, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 14, 2013
Patterns of infection in patients with myelodysplastic syndromes and acute myeloid leukemia receiving azacitidine as salvage therapy. Implications for primary antifungal prophylaxisJose F Falantes, Cristina Calderón, Francisco J Márquez-Malaver, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 10, 2012
Clinical prognostic factors for survival and risk of progression to acute myeloid leukemia in patients with myelodysplastic syndromes with < 10% marrow blasts and non-unfavorable cytogenetic categoriesJose F Falantes, Cristina Calderón, Francisco J Márquez Malaver, et al.
Journal of Biomedical Materials Research. Part A|March 27, 2012
Aging of porous silicon in physiological conditions: cell adhesion modes on scaled 1D micropatternsAlvaro Muñoz Noval, Vanessa Sánchez Vaquero, Esther Punzón Quijorna, et al.
European Journal of Haematology|May 24, 2014
Fludarabine, cyclophosphamide and rituximab as first-line treatment in patients with newly diagnosed follicular lymphomaFátima De la Cruz Vicente, Estrella Carrillo-Cruz, Maria Sole Rodriguez, et al.
Haematologica|March 12, 2010
Early intervention during imatinib therapy in patients with newly diagnosed chronic-phase chronic myeloid leukemia: a study of the Spanish PETHEMA groupFrancisco Cervantes, Pilar López-Garrido, María-Isabel Montero, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Overexpression of GYS1, MIF, and MYC is associated with adverse outcome and poor response to azacitidine in myelodysplastic syndromes and acute myeloid leukemiaJose F Falantes, Pablo Trujillo, Jose I Piruat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2016
Immunomodulatory Effect of Vitamin D after Allogeneic Stem Cell Transplantation: Results of a Prospective Multicenter Clinical TrialTeresa Caballero-Velázquez, Isabel Montero, Fermín Sánchez-Guijo, et al.
Pageof 5